BlackRock Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.22M | Buy |
38,390
+5,084
| +15% | +$162K | ﹤0.01% | 2021 |
|
|
2016
Q3 | $1.21M | Buy |
33,306
+1,665
| +5% | +$60.4K | ﹤0.01% | 1918 |
|
|
2016
Q2 | $718K | Sell |
31,641
-160
| -0.5% | -$3.63K | ﹤0.01% | 2110 |
|
|
2016
Q1 | $598K | Buy |
31,801
+3,604
| +13% | +$67.8K | ﹤0.01% | 2150 |
|
|
2015
Q4 | $463K | Sell |
28,197
-213
| -0.7% | -$3.5K | ﹤0.01% | 2220 |
|
|
2015
Q3 | $313K | Buy |
28,410
+1,100
| +4% | +$12.1K | ﹤0.01% | 2374 |
|
|
2015
Q2 | $355K | Buy |
27,310
+1,325
| +5% | +$17.2K | ﹤0.01% | 2370 |
|
|
2015
Q1 | $451K | Buy |
25,985
+930
| +4% | +$16.1K | ﹤0.01% | 2229 |
|
|
2014
Q4 | $374K | Buy |
25,055
+12,582
| +101% | +$188K | ﹤0.01% | 2326 |
|
|
2014
Q3 | $287K | Buy |
12,473
+2,990
| +32% | +$68.8K | ﹤0.01% | 2336 |
|
|
2014
Q2 | $302K | Buy |
+9,483
| New | +$302K | ﹤0.01% | 2331 |
|